Evaluation of the Safety and Pharmacokinetics of Oleander 4X in Healthy Volunteers

Cohort 1 receive 4 doses of Oleander 4X in a 24-hour period for a period of seven days.

Cohort 2 receive 2 doses of either active drug or placebo 4 times per day in a 24-hour period for a period of seven days.

Cohort 3 receive 4 doses of either active drug four times per day in a 24-hour period for a period of seven days.

The placebo group receives 4 doses of placebo in a 24-hour period for a period of 7 days